Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.39B |
| 2 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$790M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$648M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$411M |
| 5 |
Microsoft
MSFT
|
+$379M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Communication Services Select Sector SPDR ETF
XLC
|
+$344M |
| 2 |
Consolidated Edison
ED
|
+$155M |
| 3 |
iShares MSCI United Kingdom ETF
EWU
|
+$154M |
| 4 |
Vanguard Total World Stock ETF
VT
|
+$146M |
| 5 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$127M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.52% |
| 2 | Financials | 5.73% |
| 3 | Healthcare | 5.63% |
| 4 | Communication Services | 4.65% |
| 5 | Consumer Discretionary | 4.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4351
Alliance Resource Partners
ARLP
$3.26B
| $440K | ﹤0.01% |
25,918
+816
| +3% | +$14.8K |
|
4352
iShares Gold Trust
IAU
$66B
| $440K | ﹤0.01% |
16,293
+12,149
| +293% | +$304K |
|
4353
Krystal Biotech
KRYS
$9.55B
| $440K | ﹤0.01% |
10,938
-25,048
| -70% | -$819K |
|
4354
Invesco Preferred ETF
PGX
$3.78B
| $439K | ﹤0.01% |
30,000
| – | – |
|
4355
Wave Life Sciences
WVE
$1.19B
| $439K | ﹤0.01% |
16,812
+10,943
| +186% | +$307K |
|
4356
Clean Energy Fuels
CLNE
$410M
| $438K | ﹤0.01% |
164,079
+111,598
| +213% | +$324K |
|
|
SGMO
4357
PUT
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $438K | ﹤0.01% |
40,700
-5,300
| -12% | -$56.4K |
|
4358
Community Trust Bancorp
CTBI
$1.42B
| $437K | ﹤0.01% |
10,345
+5,598
| +118% | +$232K |
|
4359
KRONOS Worldwide
KRO
$947M
| $437K | ﹤0.01% |
28,547
-11,509
| -29% | -$160K |
|
4360
Commercial Vehicle Group
CVGI
$148M
| $436K | ﹤0.01% |
54,412
+35,847
| +193% | +$280K |
|
4361
Paysign
PAYS
$693M
| $436K | ﹤0.01% |
32,578
+4,894
| +18% | +$46.6K |
|
4362
UroGen Pharma
URGN
$2.22B
| $436K | ﹤0.01% |
12,126
-18,437
| -60% | -$680K |
|
|
HA
4363
CALL
DELISTED
Hawaiian Holdings, Inc.
HA
| $436K | ﹤0.01% |
15,900
-1,500
| -9% | -$40.7K |
|
|
ATCO
4364
PUT
DELISTED
Atlas Corp.
ATCO
| $436K | ﹤0.01% |
44,400
+38,600
| +666% | +$372K |
|
4365
PUT
Designer Brands
DBI
$336M
| $435K | ﹤0.01% |
22,700
+8,700
| +62% | +$178K |
|
4366
OR Royalties Inc
OR
$6.02B
| $435K | ﹤0.01% |
41,701
+41,352
| +11,849% | +$439K |
|
|
HZNP
4367
CALL
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $435K | ﹤0.01% |
18,100
-78,400
| -81% | -$1.99M |
|
4368
PennyMac Financial
PFSI
$4B
| $434K | ﹤0.01% |
19,561
+19,361
| +9,681% | +$431K |
|
|
SA
4369
Seabridge Gold
SA
$3.12B
| $434K | ﹤0.01% |
32,078
-13,397
| -29% | -$159K |
|
4370
Sprott Gold Miners ETF
SGDM
$616M
| $434K | ﹤0.01% |
792
| – | – |
|
4371
CALL
Silicon Laboratories
SLAB
$7.21B
| $434K | ﹤0.01% |
+4,200
| New | +$405K |
|
4372
Agilysys
AGYS
$3.03B
| $433K | ﹤0.01% |
20,172
+2,783
| +16% | +$57.7K |
|
4373
CALL
Patterson-UTI
PTEN
$3.83B
| $433K | ﹤0.01% |
37,600
+33,600
| +840% | +$432K |
|
|
ARQL
4374
PUT
DELISTED
Arqule Inc
ARQL
| $433K | ﹤0.01% |
+39,300
| New | +$274K |
|
4375
CALL
Lincoln National
LNC
$8.93B
| $432K | ﹤0.01% |
6,700
+3,700
| +123% | +$236K |
|
Similar funds
Barclays's Q2 2019 Portfolio in Review
As of Q2 2019, Barclays held 7,617 positions worth $163B, up 13% from $145B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Barclays deployed $14.2B of net new capital in Q2 2019, opening 457 new positions and adding to 3,922 existing holdings. Its largest new stake was Dow Inc: 2,580,874 shares worth $127M.
By sector, the portfolio is most concentrated in Technology at 8.5% of assets, up from 7.9% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street Communication Services Select Sector SPDR ETF, an estimated $344M trimmed.
- Barclays's largest Q2 2019 buy was Dow Inc: 2,580,874 shares worth $127M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q2 2019, an estimated $1.39B increase.
- Barclays's biggest Q2 2019 reduction was State Street Communication Services Select Sector SPDR ETF, cutting an estimated $344M.
- Barclays fully exited Bemis in Q2 2019, selling an estimated $33.4M.
- Barclays's ten largest holdings make up 25% of its $163B portfolio in Q2 2019.
- Barclays opened 457 new positions and closed 572 in Q2 2019.
- Barclays's portfolio value rose 13% quarter-over-quarter to $163B.
Based on Barclays's 13F filing for Q2 2019, filed 14 Aug 2019.